BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 21129328)

  • 1. The physiology of glucagon.
    Taborsky GJ
    J Diabetes Sci Technol; 2010 Nov; 4(6):1338-44. PubMed ID: 21129328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-impairment of autonomic and glucagon responses to insulin-induced hypoglycemia in dogs with naturally occurring insulin-dependent diabetes mellitus.
    Gilor C; Duesberg C; Elliott DA; Feldman EC; Mundinger TO; Taborsky GJ; Nelson RW; Havel PJ
    Am J Physiol Endocrinol Metab; 2020 Dec; 319(6):E1074-E1083. PubMed ID: 33044845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha cell dysfunction in type 1 diabetes.
    Yosten GLC
    Peptides; 2018 Feb; 100():54-60. PubMed ID: 29412832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing reduction in basal hyperglucagonaemia to repair defective glucagon counterregulation in insulin deficiency.
    Farhy LS; McCall AL
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1(0 1):133-43. PubMed ID: 21824267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pax4 transdifferentiates glucagon-secreting alpha cells to insulin-secreting beta endocrine pancreatic cells].
    Collombat P; Mansouri A
    Med Sci (Paris); 2009; 25(8-9):763-5. PubMed ID: 19765395
    [No Abstract]   [Full Text] [Related]  

  • 7. Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired alpha-cell responses in type 1 diabetes.
    Taborsky GJ; Ahrén B; Havel PJ
    Diabetes; 1998 Jul; 47(7):995-1005. PubMed ID: 9648820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain glucose sensing and neural regulation of insulin and glucagon secretion.
    Thorens B
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():82-8. PubMed ID: 21824260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autonomic mechanism and defects in the glucagon response to insulin-induced hypoglycaemia.
    Taborsky GJ; Ahren B; Mundinger TO; Mei Q; Havel PJ
    Diabetes Nutr Metab; 2002 Oct; 15(5):318-22; discussion 322-3. PubMed ID: 12625478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet α cells and glucagon--critical regulators of energy homeostasis.
    Campbell JE; Drucker DJ
    Nat Rev Endocrinol; 2015 Jun; 11(6):329-38. PubMed ID: 25850661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Type 1 Diabetes Is Characterized by an Early, Marked, Sustained, and Islet-Selective Loss of Sympathetic Nerves.
    Mundinger TO; Mei Q; Foulis AK; Fligner CL; Hull RL; Taborsky GJ
    Diabetes; 2016 Aug; 65(8):2322-30. PubMed ID: 27207540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minireview: The role of the autonomic nervous system in mediating the glucagon response to hypoglycemia.
    Taborsky GJ; Mundinger TO
    Endocrinology; 2012 Mar; 153(3):1055-62. PubMed ID: 22315452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycemia, defective islet glucagon secretion, but normal islet mass in mice with a disruption of the gastrin gene.
    Boushey RP; Abadir A; Flamez D; Baggio LL; Li Y; Berger V; Marshall BA; Finegood D; Wang TC; Schuit F; Drucker DJ
    Gastroenterology; 2003 Oct; 125(4):1164-74. PubMed ID: 14517799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes.
    Sjöberg S; Ahrén B; Bolinder J
    J Intern Med; 2002 Oct; 252(4):342-51. PubMed ID: 12366607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glucagon and glucagon-like peptides the role in control glucose homeostasis. Part I].
    Otto-Buczkowska E
    Pediatr Endocrinol Diabetes Metab; 2011; 17(4):215-21. PubMed ID: 22248782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
    Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
    Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon, insulin and somatostatin secretion in response to sympathetic neural activation in streptozotocin-induced diabetic rats. A study with the isolated perfused rat pancreas in vitro.
    Kurose T; Tsuda K; Ishida H; Tsuji K; Okamoto Y; Tsuura Y; Kato S; Usami M; Imura H; Seino Y
    Diabetologia; 1992 Nov; 35(11):1035-41. PubMed ID: 1361917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of α-Cells in Islet Function and Glucose Homeostasis in Health and Type 2 Diabetes.
    Gilon P
    J Mol Biol; 2020 Mar; 432(5):1367-1394. PubMed ID: 31954131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of glucagon secretion at low glucose concentrations: evidence for adenosine triphosphate-sensitive potassium channel involvement.
    Muñoz A; Hu M; Hussain K; Bryan J; Aguilar-Bryan L; Rajan AS
    Endocrinology; 2005 Dec; 146(12):5514-21. PubMed ID: 16123162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Models of glucagon secretion, their application to the analysis of the defects in glucagon counterregulation and potential extension to approximate glucagon action.
    Farhy LS; McCall AL
    J Diabetes Sci Technol; 2010 Nov; 4(6):1345-56. PubMed ID: 21129329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.